Sharon Bodrug is an accomplished Director of Program Management at Illumina, specializing in diagnostic product development. With a PhD from the University of Toronto, she has a proven record of leading complex, multi-disciplinary IVD and biomarker projects from initial concept through to successful commercial launch.
There is no publicly available information about her personal life, hobbies, or interests outside of her professional career.
She spearheaded the strategy and development for the first PCA3 oncology biomarker for prostate cancer, taking it from research to commercial launch while at Hologic/Gen-Probe.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.